サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ラベル付きヌクレオチドの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にラベル付きヌクレオチド市場を分類しています。
本レポートでは世界のラベル付きヌクレオチド市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Jena Bioscience、Yumpu、CJ CheilJedang Corporation、Star Lake Bioscience、ThermoFisher Scientific、Meihua Group、F. Hoffmann-La Roche、Biorigin、DSM Nutritional Products、Promega Corporation、Affymetrix、Agilent Technologies、Lallemand、Nanjing BioTogether

レポートはラベル付きヌクレオチドの主要生産者を調査し、主要地域や国の消費状況も提供します。ラベル付きヌクレオチドの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    TaqMan Allelic Discrimination
    Gene Chips & Microarrays
    SNP by Pyrosequencing

用途別の市場セグメント：
    Hospital Laboratories
    Reference Laboratories
    Academic Research Laboratories
    Other Laboratories

本レポートの詳細内容
本レポートは、世界のラベル付きヌクレオチド市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてラベル付きヌクレオチド市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のラベル付きヌクレオチド生産量、成長率、市場シェアを調査している。

二. 消費面では、ラベル付きヌクレオチドの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのラベル付きヌクレオチド売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のラベル付きヌクレオチド市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ラベル付きヌクレオチドのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ラベル付きヌクレオチドのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： ラベル付きヌクレオチドの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるラベル付きヌクレオチドの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章ラベル付きヌクレオチドメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：ラベル付きヌクレオチドの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：ラベル付きヌクレオチドの主要メーカーの概要を提供し、製品の説明と仕様、ラベル付きヌクレオチドの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ラベル付きヌクレオチドの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Labeled Nucleotides market is projected to grow from US$ 2159 million in 2024 to US$ 3313.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.
Labeled nucleotides are modified forms of nucleotides that have a specific chemical or radioactive label attached to them. These labels allow researchers to track, visualize, and detect specific nucleic acids in various molecular biology applications. Labeled nucleotides are commonly used in techniques such as DNA sequencing, PCR (polymerase chain reaction), in situ hybridization, DNA labeling, and nucleic acid microarray analysis.
Labeled nucleotides can be labeled with different types of labels, including fluorescent dyes, radioactive isotopes, or biotin. Fluorescently labeled nucleotides are widely used for fluorescence in situ hybridization (FISH), where they are incorporated into DNA or RNA probes to detect specific sequences in cells or tissues. These probes can be visualized under fluorescence microscopy, allowing for the visualization and localization of specific genetic sequences.
Radioactively labeled nucleotides, such as [32P]-labeled or [35S]-labeled nucleotides, are commonly used in techniques like DNA sequencing or autoradiography. Radioactive labels emit radiation that can be detected using specialized equipment or X-ray films, enabling the determination of nucleotide sequences or the detection of radiolabeled targets in biological samples.
Biotin-labeled nucleotides are frequently used in techniques like DNA labeling or nucleic acid microarray analysis. Biotin is a small molecule that can bind specifically to avidin or streptavidin, allowing for the indirect visualization or detection of the labeled nucleotide through the use of fluorescently or enzymatically labeled avidin/streptavidin conjugates.
The use of labeled nucleotides in molecular biology provides researchers with powerful tools for studying nucleic acids, gene expression, genetic variation, and various other molecular processes. The choice of label depends on the specific application, desired sensitivity, and detection method. Labeled nucleotides enable visualization, quantification, and analysis of nucleic acids, leading to a deeper understanding of genetic information and its role in biological processes.
Report Covers:
This report presents an overview of global market for Labeled Nucleotides, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Labeled Nucleotides, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Labeled Nucleotides, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Labeled Nucleotides sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Labeled Nucleotides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Labeled Nucleotides sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Jena Bioscience, Yumpu, CJ CheilJedang Corporation, Star Lake Bioscience, ThermoFisher Scientific, Meihua Group, F. Hoffmann-La Roche, Biorigin and DSM Nutritional Products, etc.
Market Segmentation
By Company
    Jena Bioscience
    Yumpu
    CJ CheilJedang Corporation
    Star Lake Bioscience
    ThermoFisher Scientific
    Meihua Group
    F. Hoffmann-La Roche
    Biorigin
    DSM Nutritional Products
    Promega Corporation
    Affymetrix
    Agilent Technologies
    Lallemand
    Nanjing BioTogether

Segment by Type
    TaqMan Allelic Discrimination
    Gene Chips & Microarrays
    SNP by Pyrosequencing

Segment by Application
    Hospital Laboratories
    Reference Laboratories
    Academic Research Laboratories
    Other Laboratories

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Labeled Nucleotides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Labeled Nucleotides sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Labeled Nucleotides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of TaqMan Allelic Discrimination
    Table 3. Major Manufacturers of Gene Chips & Microarrays
    Table 4. Major Manufacturers of SNP by Pyrosequencing
    Table 5. Global Labeled Nucleotides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Labeled Nucleotides Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Labeled Nucleotides Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Labeled Nucleotides Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Labeled Nucleotides Revenue Market Share by Region (2019-2024)
    Table 10. Global Labeled Nucleotides Revenue Market Share by Region (2025-2030)
    Table 11. Global Labeled Nucleotides Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Labeled Nucleotides Sales by Region (2019-2024) & (K MT)
    Table 13. Global Labeled Nucleotides Sales by Region (2025-2030) & (K MT)
    Table 14. Global Labeled Nucleotides Sales Market Share by Region (2019-2024)
    Table 15. Global Labeled Nucleotides Sales Market Share by Region (2025-2030)
    Table 16. Global Labeled Nucleotides Sales by Manufacturers (2019-2024) & (K MT)
    Table 17. Global Labeled Nucleotides Sales Share by Manufacturers (2019-2024)
    Table 18. Global Labeled Nucleotides Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Labeled Nucleotides Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Labeled Nucleotides, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Labeled Nucleotides Price by Manufacturers 2019-2024 (USD/MT)
    Table 22. Global Labeled Nucleotides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Labeled Nucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Labeled Nucleotides as of 2023)
    Table 24. Global Key Manufacturers of Labeled Nucleotides, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Labeled Nucleotides, Product Offered and Application
    Table 26. Global Key Manufacturers of Labeled Nucleotides, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 29. Global Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 30. Global Labeled Nucleotides Sales Share by Type (2019-2024)
    Table 31. Global Labeled Nucleotides Sales Share by Type (2025-2030)
    Table 32. Global Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Labeled Nucleotides Revenue Share by Type (2019-2024)
    Table 35. Global Labeled Nucleotides Revenue Share by Type (2025-2030)
    Table 36. Labeled Nucleotides Price by Type (2019-2024) & (USD/MT)
    Table 37. Global Labeled Nucleotides Price Forecast by Type (2025-2030) & (USD/MT)
    Table 38. Global Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 39. Global Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 40. Global Labeled Nucleotides Sales Share by Application (2019-2024)
    Table 41. Global Labeled Nucleotides Sales Share by Application (2025-2030)
    Table 42. Global Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Labeled Nucleotides Revenue Share by Application (2019-2024)
    Table 45. Global Labeled Nucleotides Revenue Share by Application (2025-2030)
    Table 46. Labeled Nucleotides Price by Application (2019-2024) & (USD/MT)
    Table 47. Global Labeled Nucleotides Price Forecast by Application (2025-2030) & (USD/MT)
    Table 48. US & Canada Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 49. US & Canada Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 50. US & Canada Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 53. US & Canada Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 54. US & Canada Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Labeled Nucleotides Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Labeled Nucleotides Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Labeled Nucleotides Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Labeled Nucleotides Sales by Country (2019-2024) & (K MT)
    Table 60. US & Canada Labeled Nucleotides Sales by Country (2025-2030) & (K MT)
    Table 61. Europe Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 62. Europe Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 63. Europe Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 66. Europe Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 67. Europe Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Labeled Nucleotides Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Labeled Nucleotides Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Labeled Nucleotides Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Labeled Nucleotides Sales by Country (2019-2024) & (K MT)
    Table 73. Europe Labeled Nucleotides Sales by Country (2025-2030) & (K MT)
    Table 74. China Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 75. China Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 76. China Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 79. China Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 80. China Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 83. Asia Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 84. Asia Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 87. Asia Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 88. Asia Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Labeled Nucleotides Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Labeled Nucleotides Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Labeled Nucleotides Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Labeled Nucleotides Sales by Region (2019-2024) & (K MT)
    Table 94. Asia Labeled Nucleotides Sales by Region (2025-2030) & (K MT)
    Table 95. Middle East, Africa and Latin America Labeled Nucleotides Sales by Type (2019-2024) & (K MT)
    Table 96. Middle East, Africa and Latin America Labeled Nucleotides Sales by Type (2025-2030) & (K MT)
    Table 97. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Labeled Nucleotides Sales by Application (2019-2024) & (K MT)
    Table 100. Middle East, Africa and Latin America Labeled Nucleotides Sales by Application (2025-2030) & (K MT)
    Table 101. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Labeled Nucleotides Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Labeled Nucleotides Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Labeled Nucleotides Sales by Country (2019-2024) & (K MT)
    Table 107. Middle East, Africa and Latin America Labeled Nucleotides Sales by Country (2025-2030) & (K MT)
    Table 108. Jena Bioscience Company Information
    Table 109. Jena Bioscience Description and Major Businesses
    Table 110. Jena Bioscience Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 111. Jena Bioscience Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Jena Bioscience Recent Developments
    Table 113. Yumpu Company Information
    Table 114. Yumpu Description and Major Businesses
    Table 115. Yumpu Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 116. Yumpu Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Yumpu Recent Developments
    Table 118. CJ CheilJedang Corporation Company Information
    Table 119. CJ CheilJedang Corporation Description and Major Businesses
    Table 120. CJ CheilJedang Corporation Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 121. CJ CheilJedang Corporation Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. CJ CheilJedang Corporation Recent Developments
    Table 123. Star Lake Bioscience Company Information
    Table 124. Star Lake Bioscience Description and Major Businesses
    Table 125. Star Lake Bioscience Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 126. Star Lake Bioscience Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Star Lake Bioscience Recent Developments
    Table 128. ThermoFisher Scientific Company Information
    Table 129. ThermoFisher Scientific Description and Major Businesses
    Table 130. ThermoFisher Scientific Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 131. ThermoFisher Scientific Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. ThermoFisher Scientific Recent Developments
    Table 133. Meihua Group Company Information
    Table 134. Meihua Group Description and Major Businesses
    Table 135. Meihua Group Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 136. Meihua Group Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Meihua Group Recent Developments
    Table 138. F. Hoffmann-La Roche Company Information
    Table 139. F. Hoffmann-La Roche Description and Major Businesses
    Table 140. F. Hoffmann-La Roche Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 141. F. Hoffmann-La Roche Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. F. Hoffmann-La Roche Recent Developments
    Table 143. Biorigin Company Information
    Table 144. Biorigin Description and Major Businesses
    Table 145. Biorigin Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 146. Biorigin Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Biorigin Recent Developments
    Table 148. DSM Nutritional Products Company Information
    Table 149. DSM Nutritional Products Description and Major Businesses
    Table 150. DSM Nutritional Products Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 151. DSM Nutritional Products Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. DSM Nutritional Products Recent Developments
    Table 153. Promega Corporation Company Information
    Table 154. Promega Corporation Description and Major Businesses
    Table 155. Promega Corporation Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 156. Promega Corporation Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Promega Corporation Recent Developments
    Table 158. Affymetrix Company Information
    Table 159. Affymetrix Description and Major Businesses
    Table 160. Affymetrix Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 161. Affymetrix Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Affymetrix Recent Developments
    Table 163. Agilent Technologies Company Information
    Table 164. Agilent Technologies Description and Major Businesses
    Table 165. Agilent Technologies Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 166. Agilent Technologies Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Agilent Technologies Recent Developments
    Table 168. Lallemand Company Information
    Table 169. Lallemand Description and Major Businesses
    Table 170. Lallemand Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 171. Lallemand Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Lallemand Recent Developments
    Table 173. Nanjing BioTogether Company Information
    Table 174. Nanjing BioTogether Description and Major Businesses
    Table 175. Nanjing BioTogether Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 176. Nanjing BioTogether Labeled Nucleotides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Nanjing BioTogether Recent Developments
    Table 178. Key Raw Materials Lists
    Table 179. Raw Materials Key Suppliers Lists
    Table 180. Labeled Nucleotides Distributors List
    Table 181. Labeled Nucleotides Customers List
    Table 182. Labeled Nucleotides Market Trends
    Table 183. Labeled Nucleotides Market Drivers
    Table 184. Labeled Nucleotides Market Challenges
    Table 185. Labeled Nucleotides Market Restraints
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Labeled Nucleotides Product Picture
    Figure 2. Global Labeled Nucleotides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Labeled Nucleotides Market Share by Type in 2023 & 2030
    Figure 4. TaqMan Allelic Discrimination Product Picture
    Figure 5. Gene Chips & Microarrays Product Picture
    Figure 6. SNP by Pyrosequencing Product Picture
    Figure 7. Global Labeled Nucleotides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Labeled Nucleotides Market Share by Application in 2023 & 2030
    Figure 9. Hospital Laboratories
    Figure 10. Reference Laboratories
    Figure 11. Academic Research Laboratories
    Figure 12. Other Laboratories
    Figure 13. Labeled Nucleotides Report Years Considered
    Figure 14. Global Labeled Nucleotides Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Labeled Nucleotides Revenue 2019-2030 (US$ Million)
    Figure 16. Global Labeled Nucleotides Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Labeled Nucleotides Revenue Market Share by Region (2019-2030)
    Figure 18. Global Labeled Nucleotides Sales 2019-2030 ((K MT)
    Figure 19. Global Labeled Nucleotides Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Labeled Nucleotides Sales YoY (2019-2030) & (K MT)
    Figure 21. US & Canada Labeled Nucleotides Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Labeled Nucleotides Sales YoY (2019-2030) & (K MT)
    Figure 23. Europe Labeled Nucleotides Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Labeled Nucleotides Sales YoY (2019-2030) & (K MT)
    Figure 25. China Labeled Nucleotides Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Labeled Nucleotides Sales YoY (2019-2030) & (K MT)
    Figure 27. Asia (excluding China) Labeled Nucleotides Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Labeled Nucleotides Sales YoY (2019-2030) & (K MT)
    Figure 29. Middle East, Africa and Latin America Labeled Nucleotides Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Labeled Nucleotides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Labeled Nucleotides in the World: Market Share by Labeled Nucleotides Revenue in 2023
    Figure 32. Global Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 34. Global Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 35. Global Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 36. Global Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Labeled Nucleotides Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Labeled Nucleotides Sales Share by Country (2019-2030)
    Figure 43. U.S. Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 46. Europe Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 48. Europe Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Labeled Nucleotides Revenue Share by Country (2019-2030)
    Figure 50. Europe Labeled Nucleotides Sales Share by Country (2019-2030)
    Figure 51. Germany Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 52. France Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 56. China Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 57. China Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 58. China Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 59. China Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 61. Asia Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 63. Asia Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Labeled Nucleotides Revenue Share by Region (2019-2030)
    Figure 65. Asia Labeled Nucleotides Sales Share by Region (2019-2030)
    Figure 66. Japan Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 70. India Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Labeled Nucleotides Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Labeled Nucleotides Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Labeled Nucleotides Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Labeled Nucleotides Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Labeled Nucleotides Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Labeled Nucleotides Sales Share by Country (2019-2030)
    Figure 77. Brazil Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Labeled Nucleotides Revenue (2019-2030) & (US$ Million)
    Figure 82. Labeled Nucleotides Value Chain
    Figure 83. Labeled Nucleotides Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed